William Wallace: Your Nerves Can Be Damaged Before Your Blood Shows It
William Wallace, Co-Founder and Chief Scientific Officer at Supplement Success Solutions, shared a post on LinkedIn about an article by G. Scalabrino et al. published in Progress in Neurobiology adding:
“Every nerve in your body is wrapped in myelin, a multilayered lipid sheath that insulates the axon and lets electrical signals travel fast.
B12 maintains this sheath through two separate pathways, and both fail at the same time when B12 drops.
The first pathway runs through methionine synthase.
B12 (as methylcobalamin) converts homocysteine into methionine, which becomes SAMe. SAMe provides the methyl groups needed to build phosphatidylcholine, one of myelin’s major lipid components. When B12 is low, SAMe drops and myelin lipid synthesis stalls.
The second pathway runs through methylmalonyl-CoA mutase. B12 (as adenosylcobalamin) clears methylmalonyl-CoA by converting it to succinyl-CoA. Without B12, methylmalonic acid (MMA) accumulates and abnormal fatty acids get incorporated into the myelin sheath itself, weakening its structure from the inside.
What makes this dangerous: the nerve damage can appear before anemia does. In the Lindenbaum NEJM study, 28% of patients with neuropsychiatric symptoms from B12 deficiency had completely normal blood counts. No anemia, no macrocytosis.
The myelin was already degrading with nothing on the CBC to flag it. If caught early, repletion can reverse it. If caught late, the demyelination can become permanent.”
1.Title: The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: Lessons learned from its deficiency
Autor: G. Scalabrino
2.Title: Neuropsychiatric Disorders Caused by Cobalamin Deficiency in the Absence of Anemia or Macrocytosis
Autors: John Lindenbaum, M.D., Edward B. Healton, M.D., David G.Savage, M.D., John C.M. Brust, M.D., Thomas J. Garrett, M.D., Elaine R. Podell, B.A., Paul D. Margell, B.S., Sally P.Stabler, M.D., and Robert H. Allen, M.D.
Read the Full Article on NEJM.
Find more posts featuring William Wallace on Hemostasis Today.
-
Jun 17, 2026, 05:21Finn Guo: Exploring Payment Mechanisms for Innovative Hemophilia Therapies
-
Jun 17, 2026, 04:59Wolfgang Miesbach: One-Time CRISPR Therapy Reduces Hereditary Angioedema Attacks by 87%
-
Jun 17, 2026, 04:47Ganesh Mohan: Celebrating the Heroes of Healthcare on World Blood Donor Day 2026
-
Jun 17, 2026, 04:31Ekrem Unal: Navigating the Budget Impact of Next-Generation Hemophilia Therapies in Turkey
-
Jun 17, 2026, 04:06Simon Zhao: Patient Community Promise 2025 Takes the Golden Snail Award at 14th China Rare Disease Summit
-
Jun 16, 2026, 23:47Hang Le: Singapore Study Reinforces the Need to Tackle the ”Resilience Burden” in Haemophilia
-
Jun 16, 2026, 22:07Danny Hsu: An Unforgettable Week of Science, Media and Advocacy in Stockholm
-
Jun 16, 2026, 17:36Suhasini Sil: Mitigating Grade III Plateletpheresis Reactions – A Prospective Evaluation
-
Jun 16, 2026, 17:32Presenting Pivotal Phase 3 Sickle Cell Data at EHA 2026- Agios Pharmaceuticals